These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18428067)

  • 41. Peer environment mediates parental history and individual risk in the etiology of cannabis use disorder in boys: a 10-year prospective study.
    Feske U; Tarter RE; Kirisci L; Gao Z; Reynolds M; Vanyukov M
    Am J Drug Alcohol Abuse; 2008; 34(3):307-20. PubMed ID: 18428073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Temperament pathways to childhood disruptive behavior and adolescent substance abuse: testing a cascade model.
    Martel MM; Pierce L; Nigg JT; Jester JM; Adams K; Puttler LI; Buu A; Fitzgerald H; Zucker RA
    J Abnorm Child Psychol; 2009 Apr; 37(3):363-73. PubMed ID: 18787942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic viral hepatitis is a significant contributor to the immunosenescent phenotype of parenteral drug addiction.
    Reece AS
    Addict Biol; 2009 Apr; 14(2):214-26. PubMed ID: 18811680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Personality characteristics of adults with autism spectrum disorders or attention deficit hyperactivity disorder with and without substance use disorders.
    Sizoo B; van den Brink W; Gorissen van Eenige M; van der Gaag RJ
    J Nerv Ment Dis; 2009 Jun; 197(6):450-4. PubMed ID: 19525746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attention-deficit/hyperactivity disorder and correctional health care.
    Eme RF
    J Correct Health Care; 2009 Jan; 15(1):5-18. PubMed ID: 19477807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. "Mixed hypomania" in children and adolescents: is it a pediatric bipolar phenotype with extreme diurnal variation between depression and hypomania?
    Dilsaver SC; Akiskal HS
    J Affect Disord; 2009 Jul; 116(1-2):12-7. PubMed ID: 19007995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The neuropharmacology of impulsive behaviour.
    Pattij T; Vanderschuren LJ
    Trends Pharmacol Sci; 2008 Apr; 29(4):192-9. PubMed ID: 18304658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Psychobiological determinants of risk behavior in adolescence].
    Laviola G; Macri S; Adriani W; Morley Fletcher S
    Ann Ist Super Sanita; 2002; 38(3):279-87. PubMed ID: 12645179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of impulsive behavior in drug abuse.
    Perry JL; Carroll ME
    Psychopharmacology (Berl); 2008 Sep; 200(1):1-26. PubMed ID: 18600315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disruptive, delinquent and aggressive behavior in female adolescents with a psychoactive substance use disorder: relation to executive cognitive functioning.
    Giancola PR; Mezzich AC; Tarter RE
    J Stud Alcohol; 1998 Sep; 59(5):560-7. PubMed ID: 9718109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can emotion-focused coping help explain the link between posttraumatic stress disorder severity and triggers for substance use in young adults?
    Staiger PK; Melville F; Hides L; Kambouropoulos N; Lubman DI
    J Subst Abuse Treat; 2009 Mar; 36(2):220-6. PubMed ID: 18657937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of behavioral impulsivity in the development of alcohol dependence: a 4-year follow-up study.
    Rubio G; Jiménez M; Rodríguez-Jiménez R; Martínez I; Avila C; Ferre F; Jiménez-Arriero MA; Ponce G; Palomo T
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1681-7. PubMed ID: 18631324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adolescent cortical development: a critical period of vulnerability for addiction.
    Crews F; He J; Hodge C
    Pharmacol Biochem Behav; 2007 Feb; 86(2):189-99. PubMed ID: 17222895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Let' s not be impulsive: comments on Lubman et al. (2004).
    Grant S
    Addiction; 2004 Dec; 99(12):1504-5; discussion 1506-7. PubMed ID: 15585040
    [No Abstract]   [Full Text] [Related]  

  • 55. Animal models of drug addiction: Where do we go from here?
    Olmstead MC
    Q J Exp Psychol (Hove); 2006 Apr; 59(4):625-53. PubMed ID: 16707354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impulsivity traits and neurocognitive mechanisms conferring vulnerability to substance use disorders.
    Verdejo-Garcia A; Albein-Urios N
    Neuropharmacology; 2021 Feb; 183():108402. PubMed ID: 33189766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors and prevention in adolescent substance abuse: a biopsychosocial approach.
    Briones DF; Wilcox JA; Mateus B; Boudjenah D
    Adolesc Med Clin; 2006 Jun; 17(2):335-52. PubMed ID: 16814697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensitive periods of substance abuse: Early risk for the transition to dependence.
    Jordan CJ; Andersen SL
    Dev Cogn Neurosci; 2017 Jun; 25():29-44. PubMed ID: 27840157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Substance use and the adolescent brain: a toxic combination?
    Lubman DI; Yücel M; Hall WD
    J Psychopharmacol; 2007 Nov; 21(8):792-4. PubMed ID: 17984159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Adolescence: a fertile terrain for drug abuse and addiction].
    Oliveros Calvo S
    Med Clin (Barc); 1995 May; 104(20):777-9. PubMed ID: 7783471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.